• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Synta Pharmaceuticals Corp

+ Add to Watchlist

YDO:GR

3.016 EUR 0.062 2.01%

As of 09:39:18 ET on 04/23/2014.

Snapshot for Synta Pharmaceuticals Corp (YDO)

Open: 3.153 Day's Range: 3.016 - 3.154 Volume: 0
Previous Close: 3.078 52wk Range: 2.710 - 7.860 1-Yr Rtn: -61.63%

Stock Chart for YDO

No chart data available.
  • YDO:GR 3.016
  • 1D
  • 1M
  • 1Y
3.078
Interactive YDO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for YDO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.1850
Est. PEG Ratio -
Market Cap (M EUR) 288.46
Shares Outstanding (M) 91.63
30 Day Average Volume 658
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for YDO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for YDO

Synta Pharmaceuticals Corp. is a biopharmaceutical company developing small-molecule drugs for inflammatory diseases, cancer, and diabetes. The Company has drug candidates in human clinical trials and additional programs in preclinical studies.

Keith R GollustChairman/Interim CEOVojo VukovicSenior VP/Chief Medical Ofcr
Steven B Bernitz "Steve"Senior VP:Corporate DevelopmentKeith S EhrlichVP:Finance/CFO
More Company Profile & Key Executives for YDO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil